Marksans Pharma Q4 Results: Stock jumps 12% after profit surges, margin expands

Marksans Pharma also said the impact of the revised Labour Codes relating to employee benefits resulted in a one-time charge of ₹26.1 million during FY26, which has been recognised in employee benefits expense.

Leave a Reply

Your email address will not be published. Required fields are marked *